Alzheimer’s: Scientists find early biomarkers that may predict onset
From the Medical News Today website
By 2050, 13.5 million people in the United States will live with Alzheimer’s disease unless early diagnosis and treatment can delay the onset of the disease. Current treatment centers around slowing the progression of the disease.
By 2050, 13.5 million people in the United States will live with Alzheimer’s disease unless early diagnosis and treatment can delay the onset of the disease. Current treatment centers around slowing the progression of the disease.
In the journal EMBO Molecular Medicine, scientists revealed this week that circulating microscopic nucleotides — assembled amino acids that bind directly to messenger ribonucleic acids (mRNAs) — can identify cellular imbalance in the brain. These nucleotides, called microRNAs, are easily measured blood proteins that may identify the early risk of Alzheimer’s disease.
Retiree News 
Comments are closed.